Mariner’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,455
Closed -$324K 3665
2025
Q2
$324K Sell
2,455
-1,393
-36% -$189K ﹤0.01% 2665
2025
Q1
$534K Sell
3,848
-1,161
-23% -$180K ﹤0.01% 2155
2024
Q4
$777K Buy
5,009
+984
+24% +$166K ﹤0.01% 1834
2024
Q3
$733K Sell
4,025
-302
-7% -$44.7K ﹤0.01% 1842
2024
Q2
$514K Buy
4,327
+4
+0.1% +$421 ﹤0.01% 2026
2024
Q1
$464K Buy
4,323
+693
+19% +$68.9K ﹤0.01% 2084
2023
Q4
$362K Sell
3,630
-1,846
-34% -$180K ﹤0.01% 2184
2023
Q3
$652K Buy
5,476
+3,442
+169% +$514K ﹤0.01% 1595
2023
Q2
$362K Sell
2,034
-5,609
-73% -$1.03M ﹤0.01% 1977
2023
Q1
$1.26M Sell
7,643
-9,231
-55% -$1.59M ﹤0.01% 1165
2022
Q4
$2.66M Buy
16,874
+745
+5% +$113K 0.01% 806
2022
Q3
$2.43M Buy
16,129
+1,149
+8% +$191K 0.01% 699
2022
Q2
$2.46M Buy
+14,980
New +$2.88M 0.01% 651
2021
Q4
Sell
-16,362
Closed -$3.82M 1168
2021
Q3
$3.82M Buy
16,362
+2,925
+22% +$613K 0.02% 411
2021
Q2
$2.77M Buy
+13,437
New +$2.76M 0.02% 418
2019
Q3
Sell
-1,631
Closed -$411K 845
2019
Q2
$411K Buy
1,631
+123
+8% +$28.5K ﹤0.01% 783
2019
Q1
$361K Buy
+1,508
New +$362K 0.01% 751
2018
Q4
Sell
-884
Closed -$250K 869
2018
Q3
$250K Buy
884
+10
+1% +$2.93K 0.01% 706
2018
Q2
$257K Buy
+874
New +$239K 0.01% 676

Other funds holding ICUI

Mariner's ICUI Position: Q3 2025 in Review

Mariner sold out of ICU Medical (ICUI) in Q3 2025, closing a stake of 2,455 shares — an estimated $324K sold.

Mariner first reported a position in ICUI in Q2 2018 and held it in 19 quarters. The position peaked at $3.82M in Q3 2021. 270 funds tracked by Wall St. Rank hold ICUI as of Q3 2025.

  • Mariner reported no remaining ICU Medical position as of Q3 2025 after selling out during the quarter.
  • Mariner sold 2,455 ICU Medical shares in Q3 2025, an estimated $324K.
  • Mariner first reported a position in ICU Medical in Q2 2018 and held it in 19 quarters.
  • Mariner's ICU Medical position peaked at $3.82M in Q3 2021.
  • 270 funds tracked by Wall St. Rank held ICU Medical as of Q3 2025.

Based on Mariner's 13F filing for Q3 2025, filed 14 Nov 2025.